117 related articles for article (PubMed ID: 11996328)
1. Pharmacokinetics and efficacy of 40 ml ropivacaine 7.5 mg/ml (300 mg), for axillary brachial plexus block--an open pilot study.
Wank W; Büttner J; Maier KR; Emanuelson BM; Selander D
Eur J Drug Metab Pharmacokinet; 2002; 27(1):53-9. PubMed ID: 11996328
[TBL] [Abstract][Full Text] [Related]
2. A clinical and pharmacokinetic comparison of ropivacaine and bupivacaine in axillary plexus block.
Vainionpää VA; Haavisto ET; Huha TM; Korpi KJ; Nuutinen LS; Hollmén AI; Jozwiak HM; Magnusson AA
Anesth Analg; 1995 Sep; 81(3):534-8. PubMed ID: 7653818
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block.
Hickey R; Blanchard J; Hoffman J; Sjovall J; Ramamurthy S
Can J Anaesth; 1990 Nov; 37(8):878-82. PubMed ID: 2253294
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 1% prilocaine with 0.5% ropivacaine for outpatient-based surgery under axillary brachial plexus block.
Janzen PR; Vipond AJ; Bush DJ; Hopkins PM
Anesth Analg; 2001 Jul; 93(1):187-91. PubMed ID: 11429363
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy and plasma concentrations of ropivacaine in continuous axillary brachial plexus block: high dose for surgical anesthesia and low dose for postoperative analgesia.
Salonen MH; Haasio J; Bachmann M; Xu M; Rosenberg PH
Reg Anesth Pain Med; 2000; 25(1):47-51. PubMed ID: 10660240
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia.
McGlade DP; Kalpokas MV; Mooney PH; Chamley D; Mark AH; Torda TA
Anaesth Intensive Care; 1998 Oct; 26(5):515-20. PubMed ID: 9807606
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of ropivacaine after four different techniques of brachial plexus blockade.
Rettig HC; Lerou JG; Gielen MJ; Boersma E; Burm AG
Anaesthesia; 2007 Oct; 62(10):1008-14. PubMed ID: 17845652
[TBL] [Abstract][Full Text] [Related]
8. Grand mal convulsion and plasma concentrations after intravascular injection of ropivacaine for axillary brachial plexus blockade.
Müller M; Litz RJ; Hüler M; Albrecht DM
Br J Anaesth; 2001 Nov; 87(5):784-7. PubMed ID: 11878534
[TBL] [Abstract][Full Text] [Related]
9. Improving postoperative analgesia after axillary brachial plexus anesthesia with 0.75% ropivacaine. A double-blind evaluation of adding clonidine.
Casati A; Magistris L; Beccaria P; Cappelleri G; Aldegheri G; Fanelli G
Minerva Anestesiol; 2001 May; 67(5):407-12. PubMed ID: 11382830
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of different concentrations of prilocaine and ropivacaine for intraoperative axillary brachial plexus block.
Freitag M; Zbieranek K; Gottschalk A; Bubenheim M; Winter R; Tuszynski S; Standl TG
Eur J Anaesthesiol; 2006 Jun; 23(6):481-6. PubMed ID: 16507196
[TBL] [Abstract][Full Text] [Related]
11. Combined lumbar-plexus and sciatic-nerve blocks: an analysis of plasma ropivacaine concentrations.
Vanterpool S; Steele SM; Nielsen KC; Tucker M; Klein SM
Reg Anesth Pain Med; 2006; 31(5):417-21. PubMed ID: 16952812
[TBL] [Abstract][Full Text] [Related]
12. The effects of continuous axillary brachial plexus block with ropivacaine infusion on skin temperature and survival of crushed fingers after microsurgical replantation.
Su HH; Lui PW; Yu CL; Liew CS; Lin CH; Lin YT; Chang CH; Yang MW
Chang Gung Med J; 2005 Aug; 28(8):567-74. PubMed ID: 16265847
[TBL] [Abstract][Full Text] [Related]
13. The minimum effective anesthetic volume of 0.75% ropivacaine in ultrasound-guided interscalene brachial plexus block.
Gautier P; Vandepitte C; Ramquet C; DeCoopman M; Xu D; Hadzic A
Anesth Analg; 2011 Oct; 113(4):951-5. PubMed ID: 21821517
[TBL] [Abstract][Full Text] [Related]
14. Minimum volume of local anaesthetic required to surround each of the constituent nerves of the axillary brachial plexus, using ultrasound guidance: a pilot study.
Harper GK; Stafford MA; Hill DA
Br J Anaesth; 2010 May; 104(5):633-6. PubMed ID: 20233750
[TBL] [Abstract][Full Text] [Related]
15. Analgesia and effectiveness of levobupivacaine compared with ropivacaine in patients undergoing an axillary brachial plexus block.
Cline E; Franz D; Polley RD; Maye J; Burkard J; Pellegrini J
AANA J; 2004 Oct; 72(5):339-45. PubMed ID: 15529729
[TBL] [Abstract][Full Text] [Related]
16. Tramadol does not prolong the effect of ropivacaine 7.5 mg/ml for axillary brachial plexus block.
Kesimci E; Izdes S; Gozdemir M; Kanbak O
Acta Anaesthesiol Scand; 2007 Jul; 51(6):736-41. PubMed ID: 17425616
[TBL] [Abstract][Full Text] [Related]
17. Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block.
Ala-Kokko TI; Löppönen A; Alahuhta S
Acta Anaesthesiol Scand; 2000 May; 44(5):623-6. PubMed ID: 10786752
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block.
Pere P; Salonen M; Jokinen M; Rosenberg PH; Neuvonen PJ; Haasio J
Anesth Analg; 2003 Feb; 96(2):563-9, table of contents. PubMed ID: 12538213
[TBL] [Abstract][Full Text] [Related]
19. High-resolution MRI demonstrates detailed anatomy of the axillary brachial plexus. A pilot study.
Kjelstrup T; Courivaud F; Klaastad Ø; Breivik H; Hol PK
Acta Anaesthesiol Scand; 2012 Aug; 56(7):914-9. PubMed ID: 22571443
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and clinical toxicity of prilocaine and ropivacaine following combined drug administration in brachial plexus anesthesia.
Huschak G; Rüffert H; Wehner M; Taubert MH; Preiss R; Meinecke CD; Kaisers UX; Regenthal R
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):733-43. PubMed ID: 19954712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
